Cerba Lancet Uganda Ltd v Nile International and Another (Arbitration Cause No. 5 of 2025)
Observed later treatment
No later-treatment classification is recorded for this judgment.
Citator coverage is limited to judgments in the Wakilii corpus and source-matched treatment records. Absence of a signal is not an assertion that the case remains good law.
AI-generated summary. This summary was generated by AI from the full text of the judgment. It may contain errors or omissions—always read the source judgment before relying on it.
Holding
The High Court dismissed an application to set aside an arbitral award of costs to a non-party. The court held that section 34 of the Arbitration & Conciliation Act provides for setting aside awards only in limited circumstances, none of which applied. The arbitral tribunal acted within its discretion in awarding costs to the beneficial owner of a trademark where the applicant had dealt with that entity with full knowledge and did not come to equity with clean hands. Courts reviewing arbitral awards do not function as appellate courts but decide only on legality and validity, not merits.
Outcome
Application dismissed. Arbitral award upheld.
Facts
Cerba Lancet Uganda Ltd (formerly Lancet Laboratories Uganda) and Nile International Hospital entered into a Service Level Agreement in March 2020. When a dispute arose, Nile International Hospital initiated arbitration proceedings (CAD/ARB No. 15 of 2024) against Cerba Lancet. Cerba Lancet filed a preliminary objection (Misc. Application No. 01 of 2025) arguing that Nile International Hospital was a non-existent entity lacking legal capacity, as it was not a registered company under Ugandan law and had allegedly ceased to exist in October 2018. Evidence showed that Nile International Hospital was a trademark owned by Turquoise International Healthcare Limited, which held the operational license. The arbitrator agreed that Nile International Hospital lacked capacity and dismissed the arbitration claim, but awarded costs to be paid to Turquoise International Healthcare Limited on the basis that Cerba Lancet had dealt with the entity with full knowledge and did not come with clean hands. Cerba Lancet then applied to the High Court to set aside the costs award to the non-party.
Issues
- Whether the Applicant has sufficient grounds warranting the setting aside of the arbitral award of costs to the 2nd Respondent?
Orders
- Application to set aside part of the arbitral award dismissed.
- Arbitrator's decision upheld.
- No order as to costs.
- Each party to bear its own costs.
Rules and key headnotes
Legislation cited (7)
- Arbitration & Conciliation Act Cap. 5 s.34
- Arbitration & Conciliation Act Cap. 5 s.28(5)
- Arbitration & Conciliation Act Cap. 5 s.27(2)
- Arbitration Rules (Schedule 1) r.13
- Civil Procedure Act Cap. 282 s.98
- Civil Procedure Rules S.I 71-1 Order 15 r.3
- International Arbitration Act 1974 (No. 136 of 1974 as amended) Art. 27
Cases cited (4)
- Fort Hall Bakery Supply Co v Fredrick Wangoe [1959] EA 474
- Sudhir Ruparelia and Another v Crane Bank Limited (in Receivership) (Miscellaneous Application No. 320 of 2019)
- Kyaninga Royal Cottages Ltd v Kyanyinga Lodge Limited (Miscellaneous Application No. 551 of 2018)
- Airtel Uganda Limited v Opportunity Bank Uganda Limited (Arbitration Cause No. 12 of 2023)
Full judgment
The original judgment as reported. Read the original PDF before relying on any passage.